177 related articles for article (PubMed ID: 31166946)
1. Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.
Lara A; Cong Y; Jahrling PB; Mednikov M; Postnikova E; Yu S; Munster V; Holbrook MR
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007454. PubMed ID: 31166946
[TBL] [Abstract][Full Text] [Related]
2. Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus.
Cong Y; Lentz MR; Lara A; Alexander I; Bartos C; Bohannon JK; Hammoud D; Huzella L; Jahrling PB; Janosko K; Jett C; Kollins E; Lackemeyer M; Mollura D; Ragland D; Rojas O; Solomon J; Xu Z; Munster V; Holbrook MR
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005532. PubMed ID: 28388650
[TBL] [Abstract][Full Text] [Related]
3. Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection.
Arunkumar G; Devadiga S; McElroy AK; Prabhu S; Sheik S; Abdulmajeed J; Robin S; Sushama A; Jayaram A; Nittur S; Shakir M; Kumar KGS; Radhakrishnan C; Sakeena K; Vasudevan J; Reena KJ; Sarita RL; Klena JD; Spiropoulou CF; Laserson KF; Nichol ST
Clin Infect Dis; 2019 Oct; 69(10):1752-1756. PubMed ID: 30615097
[TBL] [Abstract][Full Text] [Related]
4. Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys.
Hammoud DA; Lentz MR; Lara A; Bohannon JK; Feuerstein I; Huzella L; Jahrling PB; Lackemeyer M; Laux J; Rojas O; Sayre P; Solomon J; Cong Y; Munster V; Holbrook MR
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006978. PubMed ID: 30462637
[TBL] [Abstract][Full Text] [Related]
5. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.
Geisbert TW; Mire CE; Geisbert JB; Chan YP; Agans KN; Feldmann F; Fenton KA; Zhu Z; Dimitrov DS; Scott DP; Bossart KN; Feldmann H; Broder CC
Sci Transl Med; 2014 Jun; 6(242):242ra82. PubMed ID: 24964990
[TBL] [Abstract][Full Text] [Related]
7. The Use of Large-Particle Aerosol Exposure to Nipah Virus to Mimic Human Neurological Disease Manifestations in the African Green Monkey.
Lee JH; Hammoud DA; Cong Y; Huzella LM; Castro MA; Solomon J; Laux J; Lackemeyer M; Bohannon JK; Rojas O; Byrum R; Adams R; Ragland D; St Claire M; Munster V; Holbrook MR
J Infect Dis; 2020 May; 221(Suppl 4):S419-S430. PubMed ID: 31687756
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
[TBL] [Abstract][Full Text] [Related]
9. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.
Geisbert JB; Borisevich V; Prasad AN; Agans KN; Foster SL; Deer DJ; Cross RW; Mire CE; Geisbert TW; Fenton KA
J Infect Dis; 2020 May; 221(Suppl 4):S414-S418. PubMed ID: 31665362
[TBL] [Abstract][Full Text] [Related]
10. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.
Prasad AN; Agans KN; Sivasubramani SK; Geisbert JB; Borisevich V; Mire CE; Lawrence WS; Fenton KA; Geisbert TW
J Infect Dis; 2020 May; 221(Suppl 4):S431-S435. PubMed ID: 31665351
[TBL] [Abstract][Full Text] [Related]
11. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
[TBL] [Abstract][Full Text] [Related]
12. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
[TBL] [Abstract][Full Text] [Related]
13. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
Monath TP; Nichols R; Feldmann F; Griffin A; Haddock E; Callison J; Meade-White K; Okumura A; Lovaglio J; Hanley PW; Clancy CS; Shaia C; Rida W; Fusco J
Front Immunol; 2023; 14():1216225. PubMed ID: 37731485
[TBL] [Abstract][Full Text] [Related]
14. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.
Geisbert TW; Daddario-DiCaprio KM; Hickey AC; Smith MA; Chan YP; Wang LF; Mattapallil JJ; Geisbert JB; Bossart KN; Broder CC
PLoS One; 2010 May; 5(5):e10690. PubMed ID: 20502528
[TBL] [Abstract][Full Text] [Related]
15. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
[TBL] [Abstract][Full Text] [Related]
16. Nipah virus infects specific subsets of porcine peripheral blood mononuclear cells.
Stachowiak B; Weingartl HM
PLoS One; 2012; 7(1):e30855. PubMed ID: 22303463
[TBL] [Abstract][Full Text] [Related]
17. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
[TBL] [Abstract][Full Text] [Related]
18. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
Mire CE; Geisbert JB; Agans KN; Versteeg KM; Deer DJ; Satterfield BA; Fenton KA; Geisbert TW
Emerg Infect Dis; 2019 Jun; 25(6):1144-1152. PubMed ID: 31107231
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding of Nipah virus immunopathogenesis and anti-viral approaches.
Pelissier R; Iampietro M; Horvat B
F1000Res; 2019; 8():. PubMed ID: 31656582
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Nipah Virus Infection in Peninsular Malaysia.
Yong MY; Lee SC; Ngui R; Lim YA; Phipps ME; Chang LY
J Infect Dis; 2020 May; 221(Suppl 4):S370-S374. PubMed ID: 32392323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
